Is breast conservation therapy superior to mastectomy for women with triple-negative breast cancers?

J Clin Oncol. 2011 Jul 20;29(21):2841-3. doi: 10.1200/JCO.2011.35.8838. Epub 2011 Jun 13.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Breast Neoplasms / radiotherapy
  • Breast Neoplasms / surgery*
  • Chemotherapy, Adjuvant
  • Disease-Free Survival
  • Female
  • Humans
  • Lymphatic Metastasis
  • Mastectomy, Modified Radical / adverse effects*
  • Mastectomy, Modified Radical / mortality
  • Mastectomy, Segmental* / adverse effects
  • Mastectomy, Segmental* / mortality
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local*
  • Neoplasm Staging
  • Radiotherapy, Adjuvant
  • Receptor, ErbB-2 / analysis
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Receptors, Estrogen
  • Receptors, Progesterone
  • ERBB2 protein, human
  • Receptor, ErbB-2